Pioglitazone Cut Ischemic Cardiac Event Rate by 17%

2008 ◽  
Vol 38 (19) ◽  
pp. 18
Author(s):  
BRUCE JANCIN
Keyword(s):  
Cardiac Event ◽  
Event Rate ◽  
Cardiac Event Rate

Cardiac Morbidity and Mortality after Surgery for Gastrointestinal Carcinomas

2005 ◽  
Vol 71 (10) ◽  
pp. 833-836
Author(s):  
Matthew Lin ◽  
Jason Haukoos ◽  
Amir Tahernia ◽  
Christian De Virgilio
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Cardiac Event ◽  
Event Rate ◽  
Cardiac Risk ◽  
Clinical Risk Factors ◽  
Cardiac Events ◽  
Cardiac Morbidity ◽  
Clinical Risk ◽  
Cardiac Event Rate

The number of Americans undergoing surgery for gastrointestinal (GI) cancer is increasing, as is the prevalence of cardiovascular disease. Clinical risk factors have been found to be useful in predicting cardiac events after vascular procedures. Their utility for predicting cardiac events after GI carcinoma surgery is unclear. We performed a retrospective review in order to determine whether clinical risk factors are useful in predicting cardiac events in patients undergoing GI carcinoma surgery and to ascertain the incidence of postoperative cardiac events. From 1998 to 2003, 333 patients were identified, with an average age of 56 years. One hundred one (30.3%) patients had one or more clinical risk factors. The overall cardiac event rate was 3.9 per cent. Age >70 years was the only risk factor associated with a cardiac event. There was a trend toward increased cardiac risk with increasing number of risk factors. In the absence of clinical risk factors, cardiac events after surgery for GI carcinoma are low. There is an increased cardiac risk in patients >70 years and a trend toward increased cardiac events as the number of clinical risk factors increases.

scholarly journals Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure

2021 ◽  
Vol 8 ◽  
Author(s):  
Koichiro Watanabe ◽  
Akiomi Yoshihisa ◽  
Yu Sato ◽  
Yu Hotsuki ◽  
Fumiya Anzai ◽  
...  
Keyword(s):  
Heart Failure ◽  
Exercise Capacity ◽  
Cardiac Event ◽  
Event Rate ◽  
Characteristic Curve ◽  
Cardiopulmonary Exercise Testing ◽  
Multivariate Logistic Regression Analysis ◽  
Cardiac Events ◽  
Post Discharge ◽  
Cardiac Event Rate

Aims: We aimed to assess the associations of CAVI with exercise capacity in heart failure (HF) patients. In addition, we further examined their prognosis.Methods: We collected the clinical data of 223 patients who had been hospitalized for decompensated HF and had undergone both CAVI and cardiopulmonary exercise testing.Results: For the prediction of an impaired peak oxygen uptake (VO2) of < 14 mL/kg/min, receiver-operating characteristic curve demonstrated that the cutoff value of CAVI was 8.9. In the multivariate logistic regression analysis for predicting impaired peak VO2, high CAVI was found to be an independent factor (odds ratio 2.343, P = 0.045). We divided these patients based on CAVI: the low-CAVI group (CAVI < 8.9, n = 145) and the high-CAVI group (CAVI ≥ 8.9, n = 78). Patient characteristics and post-discharge cardiac events were compared between the two groups. The high-CAVI group was older (69.0 vs. 58.0 years old, P < 0.001) and had lower body mass index (23.0 vs. 24.1 kg/m2, P = 0.013). During the post-discharge follow-up period of median 1,623 days, 58 cardiac events occurred. The Kaplan–Meier analysis demonstrated that the cardiac event rate was higher in the high-CAVI group than in the low-CAVI group (log–rank P = 0.004). The multivariate Cox proportional hazard analysis revealed that high CAVI was an independent predictor of cardiac events (hazard ratio 1.845, P = 0.035).Conclusion: High CAVI is independently associated with impaired exercise capacity and a high cardiac event rate in HF patients.

scholarly journals Cardiac Event Rate in Hypertrophic Cardiomyopathy Patients

2011 ◽  
Vol 27 (Supplement) ◽  
pp. PE4_082
Author(s):  
Shahrul Z. Idris ◽  
Tuan N. T. ◽  
Surinder K. ◽  
Azlan H. ◽  
Zunida A. ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Cardiac Event ◽  
Event Rate ◽  
Cardiac Event Rate

Experience with Paclitaxel-Eluting Infinnium Coronary Stents

2008 ◽  
Vol 16 (6) ◽  
pp. 454-458 ◽  
Author(s):  
Mohammad A Ostovan ◽  
Reza Mollazadeh ◽  
Javad Kojuri ◽  
Mohammad Mirabadi
Keyword(s):  
Major Adverse Cardiac Event ◽  
Cardiac Event ◽  
Single Photon ◽  
Event Rate ◽  
Photon Emission ◽  
Adverse Cardiac Event ◽  
Study Endpoint ◽  
Primary Study ◽  
Cardiac Event Rate ◽  
Q Wave

To investigate the safety and efficacy of the Infinnium Paclitaxel-eluting stents in the treatment of coronary artery lesions, 196 patients with symptomatic coronary disease who received 202 stents at our center from January 2004 to November 2005 were studied prospectively. The primary study endpoint was the incidence of abnormalities on exercise electrocardiograms or cardiac single-photon emission tomography at 6 months, as a noninvasive index of stent reocclusion. Secondary endpoints were the rates of major adverse cardiac events at 1, 3, 6, 9, and 12 months. Stent deployment was successful in 98% of patients. Cumulative major adverse cardiac event rates at the end of 12 months were: cardiac death 1%, myocardial infarction 5% (Q-wave 2.5%, non-Q-wave 2.5%), and repeat revascularization of the stented lesion 3%. The overall major adverse cardiac event rate was 8.1%. There were 6 (3%) stent thromboses; all occurred late after the procedure. In patients with symptomatic ischemic heart disease, the low-cost Infinnium stent proved both effective and safe, with an acceptably low major adverse cardiac event rate.

Sign in / Sign up

Export Citation Format

Share Document